enVVeno Medical (NVNO) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.98% |
| Dec 31, 2025 | 34.62% |
| Sep 30, 2025 | 36.02% |
| Jun 30, 2025 | 10.05% |
| Mar 31, 2025 | 9.32% |
| Dec 31, 2024 | 7.02% |
| Sep 30, 2024 | -88.27% |
| Jun 30, 2024 | -31.29% |
| Mar 31, 2024 | 35.07% |
| Dec 31, 2023 | -18.87% |
| Sep 30, 2023 | 36.28% |
| Jun 30, 2023 | 20.61% |
| Mar 31, 2023 | -28.82% |
| Dec 31, 2022 | 28.66% |
| Sep 30, 2022 | 30.35% |
| Jun 30, 2022 | 8.67% |
| Mar 31, 2022 | -17.11% |
| Dec 31, 2021 | -486.29% |
| Sep 30, 2021 | -928.55% |
| Jun 30, 2021 | -2,524.11% |
| Mar 31, 2021 | -5,987.32% |
| Dec 31, 2020 | -614.07% |
| Sep 30, 2020 | -91.24% |
| Jun 30, 2020 | 64.98% |
| Mar 31, 2020 | 73.84% |
| Dec 31, 2019 | 52.30% |
| Sep 30, 2019 | 29.74% |
| Jun 30, 2019 | 24.86% |
| Mar 31, 2019 | -790.41% |
| Dec 31, 2018 | -3,427.76% |
| Sep 30, 2018 | -1,245.00% |
| Jun 30, 2018 | -37,236.16% |